Cognoa

📍 Palo Alto, United States🗓 Founded 2013👥 48 employees💰 Last funded Mar 2024
Hospitals and Health Care🌐 cognoa.com
Website LinkedIn
Cognoa innovates solutions for child developmental health. We build breakthrough products like Canvas Dx, the first and only FDA authorized autism diagnostic for children ages 1.5 to 6 years that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias. Our digital solutions are child centric and designed to find, assess, and treat developmental concerns early, within the time windows that will yield the optimal outcomes. Our proprietary "whole child" approach to AI fuels our pipeline of diagnostic and therapeutic products for autism, speech and language, ADHD, childhood anxiety, and more. For more information, visit www.cognoa.com.
2
Total investors
0
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Cognoa?
Cognoa has 2 investors on record on gritt.io, 1 mid-stage.
When did Cognoa last raise funding?
The most recent investment in Cognoa recorded on gritt.io was in March 2024.
When was Cognoa founded?
Cognoa was founded in 2013.
What industry is Cognoa in?
Cognoa operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Cognoa based?
Cognoa is headquartered in Palo Alto, United States.